Prostate Cancer Cells

Target Identification in Prostate Cancer

Limited therapeutic efficacy and drug resistance in advanced-stage prostate cancer contributes to poor outcomes, highlighting the need for targeted therapies with alternative mechanisms of action. Here, we leveraged human-centric AI to accelerate target identification for prostrate adenocarcinoma.

Written by
Elizabeth Bolitho
  • Categories
  • Target Selection
Receive the latest newsletter directly to your inbox

Overview

Poor Target-Disease Insights: 40% of Failures

Target Identification and Prioritization

Target Identification in Prostate Cancer image 0
Figure 1: Dendrogram view of for prostate adenocarcinoma identified by Causaly.
Target Identification in Prostate Cancer image 0
Figure 2: Examples of targets for prostate adenocarcinoma by relationship type: FAP,³ Rb1,⁴ HELLS⁵ and SOCS3.⁶

Conclusion

References

More on Target Selection